U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

Mutations in BRCA1 do not appear to contribute significantly to the risk of prostate cancer progression, according to DNA ...

U.S. drugmaker Amgen will invest about $200 million this year in its new technology centre in southern India, with further ...

In the final days of 2024, three pharmaceutical giants sued the federal government. In their joint lawsuit, Amgen, Eli Lilly ...

Manufacturers of medicines, including Pfizer and Eli Lilly, have spent a combined $450,000 lobbying against price caps on ...

Tirzepatide is just as effective in reducing cardiovascular risk driven by central adiposity as that driven by general ...

HYDERABAD: Reiterating the state government’s goal to make Hyderabad the world’s “China Plus One” destination, Chief Minister ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

We recently published a list of 11 Best Performing Dow Stocks So Far in 2025. In this article, we are going to take a look at ...

Hyderabad: US-based biopharma giant Amgen flagged off its first India investment with a new technology and innovation centre ...

The site is expected to accelerate Amgen’s digital capabilities through artificial intelligence and data science to further ...

Telangana government has announced Rs 5445 crore investments in Green Pharma City by 11 companies, creating 9,800 jobs.